Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7279
Rank
NZ$0.96 B
Marketcap
NZ$27.51
Share price
-0.33%
Change (1 day)
-46.20%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement